Stuart Taylor is an academic clinical radiologist specialising in gastrointestinal and oncological Imaging. His medical training was at St Bartholomew’s hospital, London and radiological training at University College Hospital, London. He also underwent specialised training in gastrointestinal imaging at St Marks Hospital, Harrow, where he undertook an MD in CT colonography. After a short time as a consultant at St Marks hospital in 2005 Stuart moved to University College Hospital as a clinical academic and was appointed Professor of Medical Imaging in 2011. Stuart is currently a NIHR senior investigator, chair of the NIHR National Imaging group and current president of the British Society of Gastrointestinal and Abdominal Radiology (BSGAR). He also sits on the executive committee of the European Society of Gastrointestinal and Abdominal Radiology (ESGAR), NIHR EME funding committee, and is a mentor for the Academy of Medical Sciences.
Stuart holds over £6M grant income as chief investigator and has published over 280 peer reviewed publications. His work has been cited over 12500 times and he has 30 publications with over 100 citations. His academic expertise aligns around gastrointestinal and oncological radiology. He has particular experience in all aspects of small bowel imaging, particularly in the context of Crohn’s disease, whole body MRI imaging, CT colonography, colorectal cancer detection and staging. Stuart's research program encompasses the translation research pipeline from first in man studies through the large scale prospective multicentre trials of imaging technology, where he has particularly expertise. He collaborates widely across institutions and disciplines such as academic clinicians and surgeons, medical physics, computationalists, academic statisticians and health economists. Stuart has successfully supervised a large number of MD and PhD students.
Summary of current research projects:
|Position||Project Title||Funder||Duration (months)||Start Year||Grant award|
|Clinical PI||Quantitative Reporting In Crohn’s Disease: Maximising Available MRI Data To Better Direct Patient Treatment, Speed Up Treatment Decisions And Improve Healthcare Outcomes 2020-2023 (academic lead)||Innovate UK||36||2020|
|Clinical PI||Real World Evidence Driving Changes in Crohn’s Disease Management Using Quantitative Imaging Analysis||NIHR i41||36||2020|
|Clinical PI||Evaluation of Crohn’s disease activity with MRI-adding value though quantitative assessment of intestinal motility||NIHR i41||36||2017||£685,467|
|Co-CI||MRI enterography as a predictor of disabling disease in newly diagnosed Crohn's disease||NIHR HTA||60||2016|
Assessment of gut transit in paediatric constipation without ionizing radiation: Magnetic Resonance Imaging transit minicapsules and methods 2 (MAGIC2) (2019-2022)
|Co-Applicant||Reclassifying constipation using MRI and high resolution manometry||MRC||48||2016||£1,225,971|
|Co-CI||Small bowel motility quantified by cine MRI as a predictor of response to biological therapy||NIHR EME||12||2016|
|Co-Applicant||Impact of multiparametric MRI on staging and management decisions in women withovarian cancer Short title: MR in Ovarian Cancer (MROC study)||NIHR HTA||60||2015|
For more information on CMI PI's full list of current and completed research grants, please follow links below: